Contract analysis

1. The Management Stockholders (Daniel Burch, Angela Moretti, Dr. Samir Patel, and Karen Tolliver) collectively hold 1,230,000 shares of Common Stock, representing 12.3% of the issued and outstanding shares of Common Stock of the Company. Individual Management Stockholder percentages aggregate to 12.3%.

2. All Subject Shares set forth in this Schedule A, taken together, represent 100% of the issued and outstanding capital stock of the Company as of the date of this Agreement. There are no other outstanding shares of capital stock or other equity interests of the Company (including options, warrants, convertible securities, or other rights to acquire equity interests of the Company) other than the Subject Shares list

3. Pursuant to the terms of the Purchase Agreement, the Management Stockholders will be rolling over approximately 24.4% of their respective Subject Shares into equity interests of the Purchaser (or a parent entity of the Purchaser) at the Closing. Specifically: (a) Daniel Burch will roll over approximately 114,680 shares; (b) Angela Moretti will roll over approximately 82,960 shares; (c) Dr. Samir Patel will roll ov

4. No Supporting Stockholder shares voting power or dispositive power over its Subject Shares with any co-holder, except as may otherwise be disclosed in the organizational documents of Crestline Growth Equity Fund II LP or Ryland Family Holdings LLC, copies of which have been provided to the Purchaser. Supporting Stockholder | Address for Notice | Type of Shares | Number / Percentage of Subject Shares | Existing Lie